Earlier this year, Pearl Pathways’ President and CEO, Diana Caldwell, began participating in her first clinical study, Cancer Research Study – 3. Caldwell plans to be more active in clinical research and to share her experiences along the way. You can read more about her experiences with this study here. Caldwell is not done volunteering, she plans to participate in Super Cure in early 2012 which is for the Susan B. Komen IU Simon Cancer Center Tissue Bank. You can follow her blogs about experiences along the way on PearlIRB.com.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.